Perspective abstract

Nature Cell Biology 6, 1021 - 1025 (2004)
doi:10.1038/ncb1104-1021

Cellular sources of new pancreatic bold beta cells and therapeutic implications for regenerative medicine

Philippe A. Halban1

Replacing missing insulin-producing beta cells to treat diabetes is a major challenge for regenerative medicine. A better understanding of beta-cell embryogenesis and regeneration in adult life is needed to devise means to derive these specialized cells in sufficiently large numbers from stem or precursor cells. It is also critical to ensure that any surrogate or regenerated beta cells have perfectly regulated insulin production, which is essential for physiological glucose homeostasis.

Top
  1. Philippe A. Halban is in the Department of Genetic Medicine and Development, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland.
    e-mail: philippe.halban@medecine.unige.ch


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Islets break off from the mainland

Nature Medicine News and Views (01 Mar 2006)

Regenerative medicine Self-help for insulin cells

Nature News and Views (06 May 2004)

See all 10 matches for News And Views

RESEARCH

In vivo reprogramming of adult pancreatic exocrine cells to &bgr;-cells

Nature Article (02 Oct 2008)

Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration

Laboratory Investigation Research Article

See all 43 matches for Research

Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Search PubMed for

Open Innovation Challenges

naturejobs

More science jobs
Post a job for free